「to you」の検索結果
101件：21～25件目を表示
もしかして
-
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eye
http://www.senju.co.jp/english/rd/pipeline.html -
Presence of Products | Overseas Activities | SENJU Pharmaceutical
e East UAE Brand Name Marketing Authorisation Holder JP Brand Name BROFIX Jamjoom Pharmaceticals Factory BRONUCK Iraq Brand Name Marketing Authorisation Holder JP Brand Name BROFIX Jamjoom Pharmacetic...
http://www.senju.co.jp/english/global/world.html -
Publications | Research & Development | SENJU Pharmaceutica
cebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2 1: Senju Pharmaceutical Co., Ltd, Hyogo, J...
http://www.senju.co.jp/english/rd/thesis/ -
千寿製薬について | 千寿製薬株式会社
CEO Message Management Policy Company Profile Our Initiatives for Society / Environment Business Activities Production system Quality policy
http://www.senju.co.jp/english/about/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
ts of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Minoru Kanamoto, MSc; Kazunori Omatsu, BSc AAO 2025 開催日：2025年10月17日～2025年10月20日 ...
http://www.senju.co.jp/english/rd/society/